“The more chemists know about how biologistsidentify and validate drug targets, the more they can help ensure a successful project out come. The first 300 pages of this volume are dedicated to just these issues, reviewed from a practicing biologist’s perspective but described completely enough to provide useful insight for the medicinal chemist and pointing to online databases and tools that enterprising chemists might try using themselves. ... The remainder of the book covers some interesting emerging technologies, as well as computational infrastructure issues. ... “...The book is wide-ranging and yet practical in its review of in silico technologies, and the medicinal chemist will pick up useful background information in important target identification and validation techniques. The authors are clearly knowledgeable about their fields, and the editors have done an excellent job of melding this multi-authored book into a cohesive whole. ...” -- Peter Gund, IBM Federal Healthcare Practice, Germantown, Maryland, USA (in the Journal of Medicinal Chemistry, 2007, Vol. 30, No. 9)